Bioavailability of fluoride in saliva after administration of fluoridated bioactive glass.

Not Applicable

• Conditions: Z29; Need for other prophylactic measures

• Registration Number: DRKS00016038
• Lead Sponsor: niversität Witten/Herdecke Professur für biologische und materialkundliche Grundlagen der Zahnmedizin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2018-08-07
• Study Start: 2018-12-05
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

Caries free, good oral health, normal saliva secretion

Exclusion Criteria

Systemic diseases, periodontitis, other oral diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary endpoint is the comparison of the fluoride concentration in saliva application of NaF, AmF and fluoridated bioactive glas at measuring points T3 and T4. <br><br>The null hypothesis is that there are no differences between the applied fluoride formulations<br><br>Secondary endpoint is the comparison of the fluoride concentration within the groups (NaF, MaF and fluoridated bioactive glass) at the measuring points T1, T2, T3 and T4 compared to T0<br>

Secondary Outcome Measures

Name	Time	Method
Comparison of the different measuring time points